These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 12545112)
61. [Cell cycle analysis and P53 gene mutation detection of fibroblasts derived from the surrounding skin of keloids]. Duan HJ; Gao JH; Shen GY Zhonghua Zheng Xing Wai Ke Za Zhi; 2003 Mar; 19(2):95-7. PubMed ID: 12889183 [TBL] [Abstract][Full Text] [Related]
62. In vitro effects of doxorubicin and mitomycin C on human Tenon's capsule fibroblasts. Saika S; Ooshima A; Yamanaka O; Kimura M; Okada Y; Tonoe O; Tanaka S; Ohnishi Y Ophthalmic Res; 1997; 29(2):91-102. PubMed ID: 9154535 [TBL] [Abstract][Full Text] [Related]
63. Increased efficiency of gamma-irradiated versus mitomycin C-treated feeder cells for the expansion of normal human cells in long-term cultures. Roy A; Krzykwa E; Lemieux R; Néron S J Hematother Stem Cell Res; 2001 Dec; 10(6):873-80. PubMed ID: 11798513 [TBL] [Abstract][Full Text] [Related]
64. Tacrolimus fails to regulate collagen expression in dermal fibroblasts. Wong VW; You F; Januszyk M; Kuang AA J Surg Res; 2013 Sep; 184(1):678-90. PubMed ID: 23647800 [TBL] [Abstract][Full Text] [Related]
65. Application of mitomycin-C for head and neck keloids. Stewart CE; Kim JY Otolaryngol Head Neck Surg; 2006 Dec; 135(6):946-50. PubMed ID: 17141089 [TBL] [Abstract][Full Text] [Related]
66. miR-141-3p inhibits fibroblast proliferation and migration by targeting GAB1 in keloids. Feng J; Xue S; Pang Q; Rang Z; Cui F Biochem Biophys Res Commun; 2017 Aug; 490(2):302-308. PubMed ID: 28619509 [TBL] [Abstract][Full Text] [Related]
67. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars. Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405 [TBL] [Abstract][Full Text] [Related]
68. Characterization of In Vitro Reconstructed Human Normotrophic, Hypertrophic, and Keloid Scar Models. Limandjaja GC; van den Broek LJ; Breetveld M; Waaijman T; Monstrey S; de Boer EM; Scheper RJ; Niessen FB; Gibbs S Tissue Eng Part C Methods; 2018 Apr; 24(4):242-253. PubMed ID: 29490604 [TBL] [Abstract][Full Text] [Related]
69. Morphological and morphometric analysis of the effects of intralesional tamoxifen on keloids. Soares-Lopes LR; Soares-Lopes IM; Filho LL; Alencar AP; da Silva BB Exp Biol Med (Maywood); 2017 May; 242(9):926-929. PubMed ID: 28440733 [TBL] [Abstract][Full Text] [Related]
70. Alterations in fibroblast alpha1beta1 integrin collagen receptor expression in keloids and hypertrophic scars. Szulgit G; Rudolph R; Wandel A; Tenenhaus M; Panos R; Gardner H J Invest Dermatol; 2002 Mar; 118(3):409-15. PubMed ID: 11874478 [TBL] [Abstract][Full Text] [Related]
71. Serum-free keloid fibroblast cell culture: an in vitro model for the study of aberrant wound healing. Koch RJ; Goode RL; Simpson GT Plast Reconstr Surg; 1997 Apr; 99(4):1094-8. PubMed ID: 9091908 [TBL] [Abstract][Full Text] [Related]
72. Dietary compounds inhibit proliferation and contraction of keloid and hypertrophic scar-derived fibroblasts in vitro: therapeutic implication for excessive scarring. Phan TT; Sun L; Bay BH; Chan SY; Lee ST J Trauma; 2003 Jun; 54(6):1212-24. PubMed ID: 12813346 [TBL] [Abstract][Full Text] [Related]
73. [An experimental study of antisense TGF-beta 1 inhibiting keloid fibroblast proliferation in vitro]. Shang Q; Yuan R; Wang W Zhonghua Zheng Xing Wai Ke Za Zhi; 2001 Nov; 17(6):325-7. PubMed ID: 11838050 [TBL] [Abstract][Full Text] [Related]
74. Dexamethasone induction of keloid regression through effective suppression of VEGF expression and keloid fibroblast proliferation. Wu WS; Wang FS; Yang KD; Huang CC; Kuo YR J Invest Dermatol; 2006 Jun; 126(6):1264-71. PubMed ID: 16575391 [TBL] [Abstract][Full Text] [Related]
75. The effect of carboxymethyl-chitosan on proliferation and collagen secretion of normal and keloid skin fibroblasts. Chen XG; Wang Z; Liu WS; Park HJ Biomaterials; 2002 Dec; 23(23):4609-14. PubMed ID: 12322982 [TBL] [Abstract][Full Text] [Related]
76. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell proliferation, invasion and collagen synthesis in keloid fibroblasts by mediating transforming growth factor-β / Smad pathway. He S; Yang Y; Liu X; Huang W; Zhang X; Yang S; Zhang X Br J Dermatol; 2012 Mar; 166(3):564-74. PubMed ID: 21967214 [TBL] [Abstract][Full Text] [Related]
77. Human serum reduces mitomycin-C cytotoxicity in human tenon's fibroblasts. Crowston JG; Wang XY; Khaw PT; Zoellner H; Healey PR Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):946-52. PubMed ID: 16505028 [TBL] [Abstract][Full Text] [Related]
78. Gallic acid inhibits fibroblast growth and migration in keloids through the AKT/ERK signaling pathway. Wang X; Liu K; Ruan M; Yang J; Gao Z Acta Biochim Biophys Sin (Shanghai); 2018 Nov; 50(11):1114-1120. PubMed ID: 30265275 [TBL] [Abstract][Full Text] [Related]
79. MiR-181a Targets PHLPP2 to Augment AKT Signaling and Regulate Proliferation and Apoptosis in Human Keloid Fibroblasts. Rang Z; Wang ZY; Pang QY; Wang YW; Yang G; Cui F Cell Physiol Biochem; 2016; 40(3-4):796-806. PubMed ID: 27915346 [TBL] [Abstract][Full Text] [Related]
80. Vitamin D: a novel therapeutic approach for keloid, an in vitro analysis. Zhang GY; Cheng T; Luan Q; Liao T; Nie CL; Zheng X; Xie XG; Gao WY Br J Dermatol; 2011 Apr; 164(4):729-37. PubMed ID: 21070203 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]